244
G. Padoan et al. / Journal of Fluorine Chemistry 178 (2015) 241–248
MS
m/z
(rel.
ab.
%):
561
([M]+ꢁ
,
5%);
476
–
MS
m/z
(rel.
ab.
%):
517
([M]+ꢁ
,
5%);
418
([M ꢀ CH2CH2CH2CH2CH2CH3]+, 10%), 228 ([M ꢀ CF3(CF2)7,
([M ꢀ CH2CH2CH2CH2CH2CH2CH3]+, 10%), 284 ([M ꢀ CF3(CF2)7, –
CH2]+, 20%), 198 ([M ꢀ CF3(CF2)8CHOHCH2]+, 100%);
CH2]+, 15%), 254 ([M ꢀ CF3(CF2)8CHOHCH2]+, 100%);
1H NMR (CD3OD):
d
= 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
1H NMR (CD3OD):
d = 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e,f,g,h),
16H); 1.04 (d-d, CH3(i), 6H); 4.1 (d-d, OH(l), 1H).
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e,f,g,h,i,l),
24H); 1.04 (d-d, CH3(m), 6H); 4.1 (d-d, OH(n), 1H).
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.8 (m, CF2(f), 2F).
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
1-Dioctylamino-4,4,5,5,6,6,7,7,8,8,9,9,9 tridecafluoro nonan-2-
2.6.2. Characterization of partially fluorinated/hydrogenated
quaternary ammonium salts (FnHm)
1-Trimethylammonium-4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11
heptadecafluoro undecan-2-ol, iodide (F8H1)
ol (A68
)
MS
m/z
(rel.
ab.
%):
617
([M]+ꢁ
,
5%);
504
([M ꢀ CH2CH2CH2CH2CH2CH2CH2CH3]+, 5%), 284 ([M ꢀ CF3(CF2)7,
–CH2]+, 10%), 254 ([M ꢀ CF3(CF2)8CHOHCH2]+, 100%);
1H NMR (CD3OD):
d
= 2.24 (m, CH2(a), 2H); 4.6 (m, CH(b), 1H);
3.51 (t, CH2(c), 2H); 3.26 (m, CH3(d), 9H); 4.7 (m, OH(e), 1H).
19F NMR (CD3OD)
1H NMR (CD3OD):
d = 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e,f,-
g,h,i,l), 24H); 1.04 (d-d, CH3(m), 6H); 4.1 (d-d, OH(n), 1H).
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
1-Diethylmethylammonium-
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11 heptadecafluoro undecan-2-
ol, iodide (F8H2)
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.8 (m, CF2(f), 2F).
1-Dimethylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol
1H NMR (CD3OD):
d = 2.46 (m, CH2(a), 2H); 4.6 (m, CH(b), 1H);
(A41
)
3.52 (m, CH2(c,d), 6H); 3.14 (s, CH3(e), 3H); 4.7 (m, CH(f), 1H); 1.37
(t, CH3(g), 6H).
MS m/z (rel. ab. %): 321 ([M]+ꢁ, 5%); 306 ([M ꢀ CH3]+, 20%), 88
([M ꢀ CF3(CF2)7, –CH2]+, 100%), 58 ([M ꢀ CF3(CF2)8CHOHCH2]+,
100%);
19F NMR (CD3OD):
d
ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m, CF2CH2(b),
2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F); ꢀ122.8 (m,
CF2(e), 2F); ꢀ121.9 (m, CF2(f), 2F); ꢀ121.6 (m, CF2(g,h), 4F).
1-Dipropylmethylammonium-
1H NMR (CD3OD):
2.49 (d, CH2(c), 2H); 2.29 (t, CH3(d), 6H); 4.2 (d, OH(e), 1H).
19F NMR (CD3OD):
d = 2.39 (m, CH2(a), 2H); 2.6 (m, CH(b), 1H);
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11 heptadecafluoro undecan-2-
ol, iodide (F8H3)
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.8 (m, CF2(f), 2F).
1H NMR (CD3OD):
d = 2.46 (m, CH2(a), 2H); 4.6 (m, CH(b), 1H);
1-Diethylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol (A42
)
3.52 (m, CH2(c,d,e), 10H); 3.14 (s, CH3(f), 3H); 4.7 (m, CH(g), 1H);
1.37 (t, CH3(h), 6H).
MS m/z (rel. ab. %): 349 ([M]+ꢁ, 10%), 116 ([M ꢀ CF3(CF2)7, –
CH2]+, 30%), 86 ([M ꢀ CF3(CF2)8CH2OHCH2]+, 100%);
19F NMR (CD3OD):
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.9 (m, CF2(f), 2F); ꢀ121.6 (m, CF2(g,h),
4F).
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
1H NMR (CD3OD):
d
= 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.04 (t, CH3(e), 6H); 4.1
(d-d, OH(f), 1H).
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
1-Dibutylmethylammonium-
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11 heptadecafluoro undecan-2-
ol, iodide (F8H4)
1-Dipropylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol (A43
)
MS m/z (rel. ab. %): 377 ([M]+ꢁ, 5%); 348 ([M ꢀ CH2CH3]+, 30%),
1H NMR (CD3OD):
d = 2.46 (m, CH2(a), 2H); 4.6 (m, CH(b), 1H);
144
([M ꢀ CF3(CF2)7,
–CH2]+,
20%),
114
3.52 (m, CH2(c,d,e,f), 14H); 3.14 (s, CH3(g), 3H); 4.7 (m, CH(h), 1H);
1.37 (t, CH3(i), 6H).
([M ꢀ CF3(CF2)8CH2OHCH2]+, 100%);
1H NMR (CD3OD):
d
= 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
19F NMR (CD3OD):
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.9 (m, CF2(f), 2F); ꢀ121.6 (m, CF2(g,h),
4F).
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e), 4H);
1.04 (d-d, CH3(f), 6H); 4.1 (d-d, OH(g), 1H).
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
1-Dihexylmethylammonium-
1-Dibutylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol (A44
)
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11 heptadecafluoro undecan-2-
ol, iodide (F8H6)
MS m/z (rel. ab. %): 405 ([M]+ꢁ, 5%); 362 ([M ꢀ CH2CH2CH3]+,
20%),
172
([M ꢀ CF3(CF2)7
,
–CH2]+,
15%),
142
1H NMR (CD3OD):
d = 2.46 (m, CH2(a), 2H); 4.6 (m, CH(b), 1H);
([M ꢀ CF3(CF2)8CH2OHCH2]+, 100%);
3.52 (m, CH2(c,d,e,f,g,h), 22H); 3.14 (s, CH3(i), 3H); 4.7 (m, CH(l),
1H); 1.37 (t, CH3(m), 6H).
1H NMR (CD3OD):
d = 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e,f), 8H);
1.04 (d-d, CH3(g), 6H); 4.1 (d-d, OH(h), 1H).
19F NMR (CD3OD):
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.9 (m, CF2(f), 2F); ꢀ121.6 (m, CF2(g,h),
4F).
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
1-Dihexylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol (A46
)
1-Dioctylmethylammonium-
MS
m/z
(rel.
ab.
%):
461
([M]+ꢁ
,
5%);
376
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11 heptadecafluoro undecan-2-
ol, iodide (F8H8)
([M ꢀ CH2CH2CH2CH2CH3]+, 20%), 228 ([M ꢀ CF3(CF2)7, –CH2]+,
10%), 198 ([M ꢀ CF3(CF2)8CH2OHCH2]+, 100%);
1H NMR (CD3OD):
d = 2.46 (m, CH2(a), 2H); 3.32 (m, CH(b), 1H);
1H NMR (CD3OD):
d
= 2.18 (m, CH2(a), 1H); 2.49 (m, CH2(a), 1H);
3.40 (m, CH2(c,d), 6H); 1.27 (t, CH2(e,f,g,h,i), 20H); 1.70 (m, CH2 (l),
4H); 0.86 (t, CH3(m), 6H); 3.14 (m, CH(n), 3H); 4.7 (t, CH3(o), 1H).
4.2 (d-d, CH(b), 1H); 2.49 (m, CH2(c,d,), 6H); 1.38 (m, CH3(e,f,g,h),
16H); 1.04 (d-d, CH3(i), 6H); 4.1 (d-d, OH(l), 1H).
19F NMR (CD3OD):
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F);
ꢀ122.8 (m, CF2(e), 2F); ꢀ121.9 (m, CF2(f), 2F); ꢀ121.6 (m, CF2(g,h),
4F).
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
19F NMR (CD3OD):
d
= ꢀ80.9 (t, CF3(a), 3F); ꢀ111.7 (m,
CF2CH2(b), 2F); ꢀ126.2 (m, CF2(c), 2F); ꢀ123.3 (m, CF2(d), 2F).
1-Dioctylamino-4,4,5,5,6,6,7,7,7 nonafluoro heptan-2-ol (A48
)